Tampa General Plans Palm Beach County Cancer Center
Tampa General Plans Palm Beach County Cancer Center TBBW
Онкология
Общие новости онкологии
3628 материалов по теме, собраны автоматически из проверенных источников
Онкология
Адвокаты больной раком Лерчек о ее лечении в Китае и следователе, который не разрешал ей обследоваться
Адвокаты больной раком Лерчек о ее лечении в Китае и следователе, который не разрешал ей обследоваться StarHit
Онкология
OncoDaily Grand Rounds at ESMO 2026: All You Need to Know About Sarcoma
OncoDaily Grand Rounds at ESMO 2026: All You Need to Know About Sarcoma Oncodaily
Онкология
В зоне риска? Кому из женщин нужно срочно бежать к онкологу и не откладывать визит на потом
В зоне риска? Кому из женщин нужно срочно бежать к онкологу и не откладывать визит на потом ФОНТАНКА.ру
Онкология
Blood Cancer Drug Denials; Body Fat and Pancreas Cancer; Studies With Fake Citations
Blood Cancer Drug Denials; Body Fat and Pancreas Cancer; Studies With Fake Citations MedPage Today
Онкология
Cathy Eng: AACR Conference Spotlights Early-Onset Cancer
Cathy Eng: AACR Conference Spotlights Early-Onset Cancer Oncodaily
Онкология
Herbert Loong Joins Global Experts for Key Oncology Insights at ESMO 2026
Herbert Loong Joins Global Experts for Key Oncology Insights at ESMO 2026 Oncodaily
Онкология
Joanna Metzner-Sadurski Advances Cancer Care Access for Rural Communities at ACCC 2026
Joanna Metzner-Sadurski Advances Cancer Care Access for Rural Communities at ACCC 2026 Oncodaily
Онкология
Reversing radiation-activated immune suppression in cancer
Reversing radiation-activated immune suppression in cancer UChicago Medicine
Онкология
Swiss Cancer Institute Team Looks Forward to Discussions and Connections With the International Oncology Community at ESMO 2026
Swiss Cancer Institute Team Looks Forward to Discussions and Connections With the International Oncology Community at ESMO 2026 Oncodaily
Онкология
ASCO Issues Its First Living Guideline on Systemic Treatment of Recurrent Ovarian Cancer
ASCO Issues Its First Living Guideline on Systemic Treatment of Recurrent Ovarian Cancer The ASCO Post
Онкология
FORTITUDE-101 and FORTITUDE-102 at ESMO 2026: Bemarituzumab Efficacy by FGFR2 Amplification Status in Gastric and GEJ Cancer
FORTITUDE-101 and FORTITUDE-102 at ESMO 2026: Bemarituzumab Efficacy by FGFR2 Amplification Status in Gastric and GEJ Cancer Oncodaily
Онкология
INCB123667 Plus Bevacizumab at ESMO 2026 Shows 48% Response Rate in Recurrent Ovarian Cancer
INCB123667 Plus Bevacizumab at ESMO 2026 Shows 48% Response Rate in Recurrent Ovarian Cancer Oncodaily
Онкология
INCB123667 Plus Bevacizumab at ESMO 2026 Shows 48% Response Rate in Recurrent Ovarian Cancer
INCB123667 Plus Bevacizumab at ESMO 2026 Shows 48% Response Rate in Recurrent Ovarian Cancer Oncodaily
Онкология
Of Note in the Oncology Community: September/October 2026
Of Note in the Oncology Community: September/October 2026 The ASCO Post
‹
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
›